ONC Stock Price and Chart — NASDAQ:ONC — TradingView

Compare with BeOne Medicines Ltd.

Key stats

Upcoming earnings

Details

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.

Financials

Performance

Revenue to profit conversion

Debt level and coverage

Earnings

Next:—

Ideas

$ONC Scenario framework Probability-weighted FV ~$400 vs spot $278 → P/FV ≈ 0.70, expected price return ~+44% (dividends excluded; ONC pays none). ScenarioProbFV/shvs SpotKey assumptionBear25%$150−46%BRUKINSA erodes into BTK competition + IRA; TNCLL disappoints; a permanent US-China biotech discount crys

by DillyDallyGally

Can a Dragon Shed Its Skin and Conquer the West?BeOne Medicines, formerly BeiGene, has executed one of the most audacious strategic pivots in recent biopharmaceutical history. In May 2025, the company redomiciled to Basel, Switzerland, rebranding itself from a Beijing-rooted biotech into a self-declared global oncology powerhouse. The move was fa

$BGNE with a Bearish outlook following its earnings #Stocks The PEAD projected a Bearish outlook for $BGNE after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 66.67%.

$BGNE with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $BGNE after a Negative under reaction following its earnings release placing the stock in drift D with an expected accuracy of 80%.

$BGNE with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $BGNE after a Positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 100%.

#6160 pull-back and hits support line $213.6 Hi Everybody #6160 pull-back and hits support line $213.6, expects to test the BLUE LINES, and stops if closes below the RED line.

by TradingWaves12345

BeiGene Announces Positive Topline Results from Phase 3 SEQUOIA BGNE: BeiGene, Ltd. 2021-07-29 20:00:00 BeiGene Announces Positive Topline Results from Phase 3 SEQUOIA Trial Comparing BRUKINSA® (Zanubrutinib) to Bendamustine Plus Rituximab in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia

by RocketTickers

BGNE Pressure Cooker Ascending triangle + bull close, strong setup and very fire

LONG BGNE Let's see if this pans out

by sojohnnysaid

BGNE short above 260$, target price 161$, about Mar 9, 2021.BGNE short above 260$, target price 161$, about Mar 9, 2021. Similar pattern of Aug 8, 2018. Wait BGNE price reached 161$, start building long position. It's not a good idea holding BGNE under 270$~260$ Long stop-Loss price : 259$ Short stop-loss price : 284$

See all ideas

Technicals

Summarizing what the indicators are suggesting.

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

An aggregate view of professional's ratings.

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Seasonals

Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock

Weight2.12%

Market value‪210.76 M‬

Weight3.86%

Market value‪107.41 M‬

Weight0.66%

Market value‪20.67 M‬

Weight0.57%

Market value‪14.00 M‬

Weight3.25%

Market value‪13.88 M‬

Weight0.80%

Market value‪9.20 M‬

Weight0.80%

Market value‪9.20 M‬

Weight9.67%

Market value‪8.55 M‬

Weight0.27%

Market value‪7.88 M‬

Weight3.20%

Market value‪6.54 M‬

Weight0.84%

Market value‪5.10 M‬

Explore more ETFs